Continuous Hyperthermic Peritoneal Perfusion Therapy for Gastric Cancer.

DOI Web Site 26 References
  • Ohkubo Kenji
    The Second Department of Surgery, Yokohama City University, School of Medicine

Bibliographic Information

Other Title
  • 胃癌に対する持続温熱腹膜潅流療法の効果

Search this article

Abstract

To elucidate the effect of continuous hyperthermic peritoneal perfusion (CHPP), 47 patients with gastric cancer in stage IVb without liver metastasis were evaluated using therapeutic parament such as adjuvant chemotherapy and clinicopathological paraments such as lymph node metastasis, peritoneal dissemination, p53 expression, vimentin expression and growth index (=%Ki67 index/%apoptosis index). Survival in pa-tients treated by CHPP have a higher tendency than that in patients treated by non-CHPP with adjuvant che-motherapy, without peritoneal dissemination and with p53 expression less than 70%(Cox-Mantel test P<0.05). But there was no significant difference of survival between in CHPP and in non-CHPP without adjuvant chemotherapy, with peritoneal dissemination and with p53 expression more than 70%. According to multi-variate analysis, peritoneal dissmination and p53 expression were determinant prognostic of gastric cancer, but CHPP was not.

Journal

References(26)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top